Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor - A pharmacokinetic study

Journal of Neuro-Oncology

Volumn 73, Issue 3, 2005, Pages 225-238

  Hamstra, Daniel A ^a   Moffat, Bradford A ^a   Hall, Daniel E ^a   Young, John M ^a   Desmond, Timothy J ^b   Carter, Julie ^a   Pietronigro, Dennis ^a   Frey, Kirk A ^a,b   Rehemtulla, Alnawaz ^a   Ross, Brian D ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Animal model; BCNU; Brain tumor; MRI; Pharmacokinetics

Indexed keywords

ALCOHOL; CARMUSTINE; DTI 015;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CANCER GRADING; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG PENETRATION; GLIOMA; HISTOPATHOLOGY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; PERFUSION WEIGHTED IMAGING; RADIODENSITOMETRY;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; AREA UNDER CURVE; BRAIN NEOPLASMS; CARMUSTINE; ETHANOL; GLIOMA; HALF-LIFE; HUMANS; INJECTIONS, INTRALESIONAL; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; RATS; TISSUE DISTRIBUTION;

EID: 22144454983     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-5675-2     Document Type: Article

References (36)

1. A Behin K Hoang-Xuan AF Carpentier JY Delattre 2003 Primary brain tumours in adults Lancet 361 323-331 10.1016/S0140-6736(03)12328-8 12559880
2. R Dorr D Hoff 1994 Carmustine In: R Dorr D Hoffs (eds) Cancer Chemotherapy Handbook Appleton and Lange Norwalk 267-275
3. LA Stewart 2002 Chemotherapy in adult high-grade glioma: A systematic review and meta- analysis of individual patient data from 12 randomised trials Lancet 359 1011-1018 10.1016/S0140-6736(02)08091-1 1:CAS:528:DC%2BD38XisV2htro%3D 11937180
4. PS Hasleton BR O'Driscoll P Lynch A Webster SJ Kalra HR Gattamaneini AA Woodcock LW Poulter 1991 Late BCNU lung: A light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma J Pathol 164 31-36 10.1002/path.1711640106 1:STN:280:By6B2sjosV0%3D 2056387
5. BR O'Driscoll PS Hasleton PM Taylor LW Poulter HR Gattameneni AA Woodcock 1990 Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood N Engl J Med 323 378-382 1:STN:280:By%2BA3MfksVI%3D 2370889
6. GR Thompson RE Larson 1969 The hepatotoxicity of 1,3-bis (2-chloroethyl)-1-nitrosurea (BCNU) in rats J Pharmacol Exp Ther 166 104-112 1:CAS:528:DyaF1MXns1egsA%3D%3D 5776013
7. FH Hochberg AA Pruitt DO Beck G DeBrun K Davis 1985 The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma J Neurosurg 63 876-880 1:STN:280:BimD3snks1Y%3D 2997415
8. SJ Hassenbusch JH Anderson DM Whiting 1990 Intra-arterial chemotherapy for brain tumors Cleve Clin J Med 57 513-520 1:STN:280:By6D1MfnvVI%3D 2268962
9. KA Walter RJ Tamargo A Olivi PC Burger H Brem 1995 Intratumoral chemotherapy Neurosurgery 37 1128-1145 1:STN:280:BymC2MbpsVA%3D 8584154
10. H Brem S Piantadosi PC Burger M Walker R Selker NA Vick K Black M Sisti S Brem G Mohr et al. 1995 Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas The Polymer-brain Tumor Treatment Group. Lancet 345 1008-1012 1:STN:280:ByqB2c%2FisVU%3D
11. BK Kleinschmidt-DeMasters 1986 Intracarotid BCNU leukoencephalopathy Cancer 57 1276-1280 1:STN:280:BimC3szgvFU%3D 3948112
12. DF Miller JW Bay RJ Lederman JD Purvis LR Rogers RL Tomsak 1985 Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas Ophthalmology 92 402-406 1:STN:280:BiqC1cbisVA%3D 2986069
13. M Westphal DC Hilt E Bortey P Delavault R Olivares PC Warnke IR Whittle J Jaaskelainen Z Ram 2003 A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro-oncol 5 79-88 1:CAS:528:DC%2BD3sXjtVKltL4%3D 12672279
14. A Olivi SA Grossman S Tatter F Barker K Judy J Olsen J Bruce D Hilt J Fisher S Piantadosi 2003 Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: A new approaches to brain tumor therapy CNS consortium trial J Clin Oncol 21 1845-1849 10.1200/JCO.2003.09.041 1:CAS:528:DC%2BD2cXpsVWqt7w%3D 12721262
15. AB Fleming WM Saltzman 2002 Pharmacokinetics of the carmustine implant Clin Pharmacokinet 41 403-419 1:CAS:528:DC%2BD38XlvFKmtbY%3D 12074689
16. RH Bobo DW Laske A Akbasak PF Morrison RL Dedrick EH Oldfield 1994 Convection-enhanced delivery of macromolecules in the brain Proc Natl Acad Sci USA, 91 2076-2080
17. M Vavra MJ Ali EW Kang Y Navalitloha A Ebert CV Allen DR Groothuis 2004 Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery Neuro-oncol 6 104-112 10.1215/S1152851703000449 1:CAS:528:DC%2BD2cXjs1Sqtb0%3D 15134624
18. JN Bruce A Falavigna JP Johnson JS Hall BD Birch JT Yoon EX Wu RL Fine AT Parsa 2000 Intracerebral clysis in a rat glioma model Neurosurgery 46 683-691 1:STN:280:DC%2BD3c7ot1Ortg%3D%3D 10719865
19. Y Mardor Y Roth Z Lidar T Jonas R Pfeffer SE Maier M Faibel D Nass M Hadani A Orenstein JS Cohen Z Ram 2001 Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging Cancer Res 61 4971-4973 1:CAS:528:DC%2BD3MXltVeqtb0%3D 11431326
20. SJ Hassenbusch EM Nardone VA Levin N Leeds D Pietronigro 2003 Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial Neoplasia 5 9-16 1:CAS:528:DC%2BD3sXhs12ltL8%3D 12659665
21. D Pietronigro F Drnovsky H Cravioto J Ransohoff 2003 DTI-015 produces cures in T9 gliosarcoma Neoplasia 5 17-22 1:CAS:528:DC%2BD3sXhs12ltLw%3D 12659666
22. TL Chenevert PE McKeever BD Ross 1997 Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging Clin Cancer Res 3 1457-1466 1:STN:280:DyaK1M7htFSrsg%3D%3D 9815831
23. DE Hall BA Moffat J Stojanovska TD Johnson Z Li DA Hamstra A Rehemtulla TL Chenevert J Carter D Pietronnigro BD Ross 2004 Therapeutic Efficacy of DTI-015 using diffusion MRI as an early surrogate marker Clin Cancer Res 10 7852-7859 1:CAS:528:DC%2BD2cXhtVCrs7zL 15585617
24. BD Ross H Merkle K Hendrich RS Staewen M Garwood 1992 Spatially localized in vivo 1H magnetic resonance spectroscopy of an intracerebral rat glioma Magn Reson Med 23 96-108 1:STN:280:By2C3s%2FnvFc%3D 1734186
25. M Colvin RB Brundrett W Cowens I Jardine DB Ludlum 1976 A chemical basis for the antitumor activity of chloroethylnitrosoureas Biochem Pharmacol 25 695-699 10.1016/0006-2952(76)90246-X 1:CAS:528:DyaE28XkslajtrY%3D 945062
26. VT DeVita C Denham JD Davidson VT Oliverio 1967 The physiological disposition of the carcinostatic 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in man and animals Clin Pharmacol Ther 8 566-577 1:CAS:528:DyaF2sXkslagurs%3D 4951973
27. VA Levin W Hoffman RJ Weinkam 1978 Pharmacokinetics of BCNU in man: A preliminary study of 20 patients Cancer Treat Rep 62 1305-1312 1:STN:280:CSaD3c7ntVc%3D 688274
28. BD Ross YJ Zhao ER Neal LD Stegman M Ercolani O Ben-Yoseph TL Chenevert 1998 Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: An MRI study Proc Natl Acad Sci USA, 95 7012-7017
29. TL Chenevert LD Stegman JM Taylor PL Robertson HS Greenberg A Rehemtulla BD Ross 2000 Diffusion magnetic resonance imaging: An early surrogate marker of therapeutic efficacy in brain tumors J Natl Cancer Inst 92 2029-2036 10.1093/jnci/92.24.2029 1:STN:280:DC%2BD3M3jt1eisQ%3D%3D 11121466
30. WJ Bodell DD Giannini S Singh D Pietronigro VA Levin 2003 Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015 J Neurooncol 62 251-258 10.1023/A:1023383717833 12777076
31. WJ Bodell DD Giannini S Hassenbusch VA Levin 2001 Levels of N7-(2-hydroxyethyl)guanine as a molecular dosimeter of drug delivery to human brain tumors Neuro-oncol 3 241-245 10.1215/S1522851701000035 1:CAS:528:DC%2BD38Xks1Olsro%3D 11584893
32. L Simpson-Herren D Pietronigro 1999 Intratumoral injection of DTI-015 in the Walker 256 subcutaneous model Proc Am Assoc Cancer Res 58 pp.
33. BD Ross TL Chenevert B Kim O Ben-Yoseph 1994 Magnetic resonance imaging and spectroscopy: Application to experimental neuro-oncology Q Magn Reson Biol Med 1 89-106
34. RD Fross PC Warnke DR Groothuis 1991 Blood flow and blood-to-tissue transport in 9L gliosarcomas: The role of the brain tumor model in drug delivery research J Neurooncol 11 185-197 10.1007/BF00165526 1:STN:280:By2A2szivVU%3D 1823340
35. RG Steen MM Graham 1991 31P magnetic resonance spectroscopy is sensitive to tumor hypoxia: Perfusion and oxygenation of rat 9L gliosarcoma after treatment with BCNU NMR Biomed 4 117-124 1:STN:280:By2D3c7hsVA%3D 1911098
36. Moffat B, Chenevert T, Hall D, Rehemtulla A, Ross B: Quantitative perfusion imaging by continuous inversion using pulse trained arterial spin labeling. J Magn Reson Imaging, in press